Strongbridge Bio Ord
(SBBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,101 | -12,205 | -43,633 | -33,183 | -23,517 |
| Depreciation Amortization | 5 | 3 | 11 | 8 | 6 |
| Income taxes - deferred | -926 | -55 | -450 | -306 | -177 |
| Accounts payable and accrued liabilities | -827 | -1,488 | 1,737 | 3,443 | 7,065 |
| Other Working Capital | 87 | 1,084 | 1,783 | 2,219 | 4,557 |
| Other Operating Activity | 9,023 | 3,366 | 3,192 | 317 | -3,599 |
| Operating Cash Flow | $-17,739 | $-9,295 | $-37,360 | $-27,502 | $-15,665 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -25 | -25 | -25 |
| Net Acquisitions | N/A | N/A | -4,269 | -3,168 | -3,168 |
| Investing Cash Flow | $N/A | $N/A | $-4,294 | $-3,193 | $-3,193 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 412 | N/A |
| Common Stock Issued | N/A | N/A | 77,816 | 57,931 | 58,298 |
| Other Financing Activity | 0 | 0 | -412 | 0 | 0 |
| Financing Cash Flow | $N/A | $N/A | $77,404 | $58,343 | $58,298 |
| Exchange Rate Effect | N/A | -21 | 241 | -348 | -685 |
| Beginning Cash Position | 51,623 | 51,623 | 15,632 | 15,632 | 15,632 |
| End Cash Position | 33,884 | 42,307 | 51,623 | 42,932 | 54,387 |
| Net Cash Flow | $-17,739 | $-9,316 | $35,991 | $27,300 | $38,755 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,739 | -9,295 | -37,360 | -27,502 | -15,665 |
| Capital Expenditure | N/A | N/A | -25 | -25 | -25 |
| Free Cash Flow | -17,739 | -9,295 | -37,385 | -27,527 | -15,690 |